Nurix Therapeutics Announces Publication in the Journal Science Identifying a New Class of BTK Mutations That Are Susceptible to NX-2127, a Novel BTK and IKZF1/3 Degrader
GlobeNewswire
Data reveal oncogenic scaffold function of BTK mutations that lack kinase activity and show these mutations remain susceptible to..